Alexander M. Vezeridis, Ph.D. - Publications
Affiliations: | 2011 | Boston University, Boston, MA, United States |
Area:
BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Fotakis P, Vezeridis A, Dafnis I, Chroni A, Kardassis D, Zannis VI. apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL. Journal of Lipid Research. 55: 1310-1323. PMID 24776540 DOI: 10.1194/Jlr.M048348 | 0.702 | |||
2012 | Koupenova M, Johnston-Cox H, Vezeridis A, Gavras H, Yang D, Zannis V, Ravid K. A2b adenosine receptor regulates hyperlipidemia and atherosclerosis. Circulation. 125: 354-63. PMID 22144568 DOI: 10.1161/Circulationaha.111.057596 | 0.482 | |||
2011 | Georgiadou D, Chroni A, Vezeridis A, Zannis VI, Stratikos E. Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia. Plos One. 6: e27037. PMID 22069485 DOI: 10.1371/Journal.Pone.0027037 | 0.65 | |||
2011 | Vezeridis AM, Chroni A, Zannis VI. Domains of apoE4 required for the biogenesis of apoE-containing HDL. Annals of Medicine. 43: 302-11. PMID 21604997 DOI: 10.3109/07853890.2010.549143 | 0.679 | |||
2011 | Vezeridis AM, Drosatos K, Zannis VI. Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4. Journal of Lipid Research. 52: 45-56. PMID 20861163 DOI: 10.1194/Jlr.M008409 | 0.697 | |||
2009 | Zannis V, Drosatos K, Kypreos K, Vezeridis A, Chroni A. Abstract: 1498 THE ROLE OF APOLIPOPROTEIN E IN TRIGLYCERIDE HOMEOSTASIS AND THE BIOGENESIS OF HDL Atherosclerosis Supplements. 10: e190. DOI: 10.1016/S1567-5688(09)70195-3 | 0.574 | |||
2008 | Zannis VI, Koukos G, Drosatos K, Vezeridis A, Zanni EE, Kypreos KE, Chroni A. Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models. Annals of Medicine. 40: 14-28. PMID 18246469 DOI: 10.1080/07853890701687219 | 0.692 | |||
Show low-probability matches. |